Occidental Petroleum Corporation (OXYP34)
Sao Paulo Exchange · Brazil · prices in BRL · close of 23 Oct 2026
Key indicators
| Last close | BRL 52.33 |
|---|---|
| 52-week range | 35.39 – 58.69 |
| Return, 1 month / 3 months | +5.7% / +7.1% |
| Return, 1 year / 3 years | +37.0% / +3.1% |
| Trend | Uptrend |
| RSI (14) | 57 |
| Volatility (1 year) | 39.7% |
| Worst drawdown (1 year) | -28.7% |
| Average daily value traded | 0.13M BRL |
| Dividend yield | 4.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Occidental Petroleum Corporation is an energy company based in Houston, Texas, that explores for and produces crude oil and natural gas, with major operations in the Permian Basin of the United States as well as in the Middle East and other regions. Through its chemical arm, it manufactures chlorine, caustic soda and related industrial chemicals. Its customers include energy markets, industrial buyers and chemical users around the world.
Occidental Petroleum Corporation is represented on the Sao Paulo Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code OXYP34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Occidental Petroleum Corporation (OXYP34) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 52.33 on 23 October 2026.
Its price-based Market X-Ray is 63 out of 100 (a fair price profile), ranking 336 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 37.0% and over the last three months it rose 7.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 72 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 10.4% | ||
| From 52-week high | -10.8% | ||
| Momentum | 70 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 7.1% | ||
| 6-month return | 8.9% | ||
| 12-month return, skipping the last month | 29.6% | ||
| Stability (higher is calmer) | 50 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 39.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -28.7% | ||
| Liquidity | 61 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.13M BRL | ||
| Zero-volume days | 1.7% | ||
| Income | 57 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.2% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −0.8% |
|---|---|
| 1 month | +5.7% |
| 3 months | +7.1% |
| 6 months | +8.9% |
| 1 year | +37.0% |
| 3 years | +3.1% |
| 5 years | +74.4% |
Signals
| 50-day / 200-day average | 51.05 / 47.41 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.57 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 8 Jun 2026 | USD 0.1494 |
| 6 Mar 2026 | USD 0.1466 |
| 8 Dec 2025 | USD 0.1455 |
| 8 Sep 2025 | USD 0.1471 |
| 6 Jun 2025 | USD 0.1508 |
| 6 Mar 2025 | USD 0.1591 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.